GRACECast - LCVL- What are the options after a patient with an ALK-positive advanced NSCLC develops resistance on Alecensa-alectinib
Mar 24, 2021 ·
5m 41s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Dr. Caroline McCoach discusses What are the options after a patient with an ALK-positive advanced NSCLC develops resistance on Alecensa-alectinib
Information
| Author | cancerGRACE |
| Organization | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
